NASDAQ: XWEL

XWELL, Inc.

CIK 0001410428 · SIC 7200 · Personal Services

Micro Revenue $29M Assets $21M as of Aug 26, 2026

XWELL is a global wellness organization dedicated to delivering restorative and health-focused services to travelers through its three reportable operating segments: XpresSpa®, XpresTest®, and Naples Wax Center®. As of the date of this Annual Report on Form 10-K, XWELL currently has three… About this business →

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (HPQ 10-Q) is open in full — no account needed.

10-Q Filed Aug 14, 2026 · Period ending Jun 30, 2026

Summary not yet generated.

8-K Filed Aug 5, 2026 · Period ending Aug 3, 2026

Summary not yet generated.

Partner

Trade XWEL commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Jul 9, 2026 · Period ending Jul 6, 2026

Summary not yet generated.

10-Q Filed May 20, 2026 · Period ending Mar 31, 2026 Red flag

revenue $6.6M, net income -$11.2M. XWELL raises, eliminates going-concern warning, but G&A expenses surge 76%

5 material changes detected. Sign up free to read the summary.

10-K/A Filed Apr 30, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

8-K Filed Apr 1, 2026 · Period ending Apr 1, 2026

XWELL announces fiscal year 2025 financial results and corporate update

2 material changes detected. Sign up free to read the summary.

10-K Filed Apr 1, 2026 · Period ending Dec 31, 2025 Red flag

revenue $29.2M, net income -$17.0M. XWELL posts 14% revenue decline, impairs Naples Wax goodwill; Series H financing lifts going-concern doubt

5 material changes detected. Sign up free to read the summary.

8-K Filed Mar 4, 2026 · Period ending Feb 26, 2026

Summary not yet generated.

8-K Filed Feb 25, 2026 · Period ending Feb 24, 2026

Summary not yet generated.

10-Q Filed Nov 14, 2025 · Period ending Sep 30, 2025

Summary not yet generated.

10-Q Filed May 20, 2025 · Period ending Mar 31, 2025

Summary not yet generated.

10-K Filed Apr 15, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

Latest financial statements

From 10-Q filed Aug 14, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

(In thousands, except share and per share data)

Description Three months ended June 30, 2026 Three months ended June 30, 2025 Six months ended June 30, 2026 Six months ended June 30, 2025
Revenue, net
Services 6,531 6,905 12,596 13,325
Products 614 784 1,188 1,387
Total revenue, net 7,145 7,689 13,784 14,712
Cost of sales
Labor 3,037 3,912 6,011 7,879
Occupancy 606 1,238 1,367 2,372
Products and other operating costs 554 764 1,104 1,367
Total cost of sales 4,197 5,914 8,482 11,618
Gross Profit 2,948 1,775 5,302 3,094
Depreciation and amortization 163 187 335 353
Loss on disposal of assets, net 239 239
General and administrative 4,650 4,280 12,246 8,591
Total operating expenses 5,052 4,467 12,820 8,944
Operating loss (2,104) (2,692) (7,518) (5,850)
Change in fair value of derivative liabilities 421 (5,584) 279
Change in fair value of warrant liability 625 3,215
Loss on issuance of Series G Preferred Stock (3,443)
Interest income (expense), net 11 147 (32) 204
Foreign exchange gain (loss) 102 (543) 179 (998)
Gain on investments, realized and unrealized 188 58 166 54
Other non-operating expense, net (29) (34) (55) (67)
Loss before income taxes (1,832) (2,018) (12,844) (6,606)
Income tax expense (51) (34) (51) (34)
Net loss (1,883) (2,052) (12,895) (6,640)
Net income attributable to noncontrolling interests (357) (217) (547) (348)
Net loss attributable to XWELL, Inc. (2,240) (2,269) (13,442) (6,988)
Net loss (1,883) (2,052) (12,895) (6,640)
Other comprehensive income (loss) (41) 417 (119) 606
Comprehensive loss (1,924) (1,635) (13,014) (6,034)
Loss per share
Preferred stock dividends (189) (82) (257)
Preferred stock accretion (583) (1,082)
Deemed contribution on Repurchase of Series G Preferred Stock 106
Net loss attributable to XWELL, Inc. common stockholders (2,240) (3,041) (13,418) (8,327)
Basic and diluted loss per share (0.26) (0.56) (1.69) (1.56)
Weighted-average number of shares outstanding
Basic 8,487,425 5,417,271 7,944,801 5,340,442
Diluted 8,487,425 5,417,271 7,944,801 5,340,442

Condensed Consolidated Balance Sheets (Unaudited)

(In thousands, except share and per share data)

Description June 30, 2026 December 31, 2025
Current assets
Cash and cash equivalents 11,778 2,617
Marketable securities 7
Accounts receivable, net 1,824 1,560
Inventory 391 509
Other current assets 1,146 1,217
Total current assets 15,139 5,910
Restricted cash 568 251
Property and equipment, net 1,606 1,665
Intangible assets, net 20 101
Operating lease right-of-use assets, net 836 1,039
Security deposits 2,067 2,127
Other assets 290 124
Total assets 20,526 11,217
Current liabilities
Accounts payable 1,618 2,836
Accrued expenses and other current liabilities 2,657 2,940
Accrued Series G convertible preferred stock redemption payable 538
Current portion of operating lease liabilities 1,685 1,862
Deferred revenue 708 1,126
Convertible senior secured note, net 3,590
Total current liabilities 6,668 12,892
Long-term liabilities
Derivative liability 3,870
Operating lease liabilities 5,606 7,035
Total liabilities 12,274 23,797
Commitments and contingencies (see Note 8)
Temporary equity
Series G Convertible Preferred Stock, $0.01 par value per share and $1,000 stated value per share, 4,000 shares authorized; 0 and 196 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively; Liquidation preference of $0 as of June 30, 2026 224
Equity (deficit)
Series H Convertible Preferred Stock, $0.01 par value per share and $1,000 stated value per share, 35,000 shares authorized; 31,333 and 0 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively; Liquidation preference of $31,333 as of June 30, 2026
Common stock, $0.01 par value per share, 150,000,000 shares authorized; 8,471,766 and 6,071,324 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively 84 61
Additional paid-in capital 502,962 468,915
Accumulated deficit (503,139) (489,697)
Accumulated other comprehensive loss (1,761) (1,541)
Total equity (deficit) attributable to XWELL, Inc. (1,854) (22,262)
Noncontrolling interests 10,106 9,458
Total equity (deficit) 8,252 (12,804)
Total liabilities, temporary equity and equity 20,526 11,217

Condensed Consolidated Statements of Cash Flows (Unaudited)

(In thousands)

Description Six months ended June 30, 2026 Six months ended June 30, 2025
Cash flows from operating activities
Net loss (12,895) (6,640)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization 335 353
Unrealized gain on marketable securities (33)
Foreign currency remeasurement (gain) loss (179) 998
Gain on lease termination (501) (401)
Loss on disposal of assets, net 239
Amortization of operating lease right-of-use asset 158 490
Provision for credit losses (4) 6
Stock-based compensation 984 682
Non-cash interest expense 53
Gain on equity investment (166) (20)
Change in fair value of derivative liability 5,584 (279)
Change in fair value of warrant liability (3,215)
Loss on issuance of Series G Preferred Stock 3,443
Changes in assets and liabilities:
Decrease (increase) in inventory 117 (59)
(Increase) decrease in accounts receivable (259) 278
(Decrease) in deferred revenue (417) (106)
Decrease (increase) in other assets, current and non-current 96 (1,013)
(Decrease) in other liabilities, current and non-current (1,196) (1,287)
(Decrease) increase in accounts payable (1,066) 239
Net cash used in operating activities (9,117) (6,564)
Cash flows from investing activities
Acquisition of property and equipment (559) (1,313)
Investment in marketable securities (84)
Sale of marketable securities 7 4,488
Net cash provided by (used in) investing activities (552) 3,091
Cash flows from financing activities
Payment of Series G Preferred Stock dividends (76) (95)
Payments for shares withheld on vesting
Payment for Repurchase of preferred stock, convertible notes and warrants (9,000)
Proceeds from Series H Preferred Stock in private placement, net of offering costs 28,269 3,745
Net cash provided by financing activities 19,193 3,650
Effect of exchange rate changes on cash, cash equivalents and restricted cash (46) 36
Increase in cash, cash equivalents and restricted cash 9,478 213
Cash, cash equivalents, and restricted cash at beginning of the year 2,868 5,301
Cash, cash equivalents, and restricted cash at end of the period 12,346 5,514
Cash paid for
Income taxes 51 34
Non-cash investing and financing transactions
Capital expenditures included in accounts payable, accrued expenses and other current liabilities (125) 16
Accrual of Series G convertible preferred stock dividends 82 162
Accretion of Series G convertible preferred stock to redemption value 1,082
Initial fair value of warrant liability 5,873
Initial fair value of derivative liability 1,315
Accrued Series G convertible preferred stock redemption payable 829
Reclass of warrant liability upon warrant modification 2,658
Derecognition of right-of-use asset and operating lease liabilities upon termination of lease 47
Lease liability remeasurement due to modification 79
Noncash conversion of Series G convertible preferred stock 543
Deemed dividend on Repurchase of Series G Preferred Stock 106
Fair value of Placement Agent warrants 7,152
Contribution on Repurchase of related party debt, net of warrant repurchase cost 4,250

Amounts as printed on the EDGAR/iXBRL face — (In thousands, except share and per share data); (In thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗

About XWELL, Inc.

Source: Item 1 (Business) from the 10-K filed April 1, 2026. Description as filed by the company with the SEC.

ITEM 1. BUSINESS

Overview

XWELL is a global wellness organization dedicated to delivering restorative and health-focused services to travelers through its three reportable operating segments: XpresSpa®, XpresTest®, and Naples Wax Center®. As of the date of this Annual Report on Form 10-K, XWELL currently has three reportable operating segments: XpresSpa®, XpresTest® and Naples Wax Center®.

On October 25, 2022, the Company changed its name to XWELL, Inc. (“XWELL” or the “Company”) from XpresSpa Group, Inc. The Company’s common stock, par value $0.01 per share, which had previously been listed under the trading symbol “XSPA” on Nasdaq, now trades under the trading symbol “XWEL”. The Company filed an amended and restated certificate of incorporation with the Delaware Secretary of State on October 24, 2022 (as amended, the “Amended and Restated Certificate”) reflecting the name change. Rebranding to XWELL aligned the Company’s corporate strategy to build a pure-play wellness services company, in both the airport and off-airport marketplaces.

All amounts are in thousands, except share, per share, or as otherwise specifically noted.

XpresSpa

XWELL’s subsidiary, XpresSpa Holdings, LLC (“XpresSpa”) has been a global airport retailer of spa services through its XpresSpa spa locations, offering travelers premium spa services, including massage, nail and skin care, as well as spa and travel products.

As of December 31, 2025, there were 16 domestic XpresSpa locations in total. The Company also had 9 international locations operating as of December 31, 2025, including 2 XpresSpa locations in the Dubai International Airport in the United Arab Emirates, 1 XpresSpa location in the Zayad International Airport in Abu Dhabi, United Arab Emirates, 2 XpresSpa locations in the Schiphol Amsterdam Airport in the Netherlands and 4 XpresSpa locations in the Istanbul Airport in Turkey.

Read full description ↓

Treat, which is operating through XWELL’s subsidiary Treat, Inc. (“Treat”) is a wellness brand that provides access to wellness services for travelers at on-site centers. In April 2024, the decision was made to close the location in the Salt Lake City International Airport. In the first quarter of 2025, the decision was made to convert the final remaining Treat location at JFK International Airport in New York City to an XWELL location. As of December 31, 2025 all Treat locations have been converted to XWELL.

XpresTest

The Company, in partnership with certain COVID-19 testing partners, successfully launched its XpresCheck Wellness Centers, in June of 2020, through its XpresTest, Inc. subsidiary (“XpresTest”), which offered COVID-19 and other medical testing to the traveling public, as well as airline, airport and concessionaire employees, and TSA and U.S. Customs and Border Protection agents during the pandemic. As of December 31, 2023, the Company closed all XpresCheck locations and XpresTest no longer provides diagnostic testing services XpresTest began conducting bio surveillance monitoring with the Centers for Disease Control and Prevention (CDC) in collaboration with Concentric by Ginkgo Bioworks Holdings, Inc. (“Ginkgo Bioworks”) in 2021.

The program was renewed through August 2024. The revenue to XpresTest from such one-year extension totaled approximately $7,044. In January 2024, the program funding and scope were expanded, a revenue increase of $4,000, to an estimated $11,044 in revenue for XpresTest with new collection locations at U.S. international airports and the roll out of multi-pathogen testing across the program. In July 2024, the contract was further amended to extend the time period for services by two weeks (extension period August 12, 2024 to August 25, 2024). An increase of $293 in revenue for the two week extension brought total revenue to $11,337. The program was again extended in August 2024 through February 25,

2025. The funding was expanded with a revenue increase of $3,763, to an estimated $15,100 in revenue for XpresTest. In February 2025, the program was extended through a three-year contract with a total base value of $22,200 over three years, and a maximum ceiling value of $24,800 within the same timeframe.

Naples Wax Center

XWELL’s subsidiary Naples Wax, LLC, d/b/a Naples Wax Centers (“Naples Wax Center” or “Naples Wax”) which was acquired on September 12, 2023, for a purchase price of $1,624, operates a group of upscale hair removal locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products. The acquisition of Naples Wax Center is intended to enable us to move beyond our airport client base with a business that can be adapted to a larger wellness platform while also growing our retail footprint to serve our long-term financial goals.

Although we recognize four segments of business, we believe there is opportunity to leverage a segment of our products and services across our platform of brands. Additionally, we are expanding our retail strategy, not only adding more products for sale but aligning those products more efficiently to our service offerings. This product strategy includes, for example, adding muscle relaxation patches to a neck or back massage to continue treatment after the delivery of the service.

We also plan to build our capability for delivering health and wellness services outside of the airport. We believe operating outside of the airport complements our offering and represents the fastest way to scale the XWELL family of brands.

We will be looking to further expand internationally. We believe a strategy for international expansion further advances our ability to expand our other brands including bio surveillance outside of the US.

Our Strategy and Outlook

We believe our company is strategically positioned to capitalize on the growing consumer interest in travel, health, and wellness, as well as the increasing demand for related products and services. Our forward-looking plan focuses on expanding and integrating offerings across our brands, with a key emphasis on unifying airport and off-airport locations under the XWELL brand. This strategic alignment will enable the development of membership programs that provide seamless access to XWELL locations, fostering deeper customer relationships and enhancing brand loyalty. Additionally, a strong customer community will support targeted marketing initiatives and cross-promotional opportunities.

As part of our strategy, we will optimize our airport portfolio to create a leaner, more profitable business while leveraging the high foot traffic of airport locations to build brand recognition. Simultaneously, we will pursue an off-airport growth strategy through acquisitions, particularly in the expanding med spa sector, which includes health, wellness, and beauty services. Our plan includes both developing new locations and acquiring established med spas, strategically expanding XWELL’s presence in key metropolitan areas that align with our existing airport locations. This approach will enhance membership accessibility and strengthen our brand’s reach.

Additionally, our expertise from the XpresTest unit will allow us to expand bio-security services beyond the U.S. through partnerships with government clients. Domestically, we will continue growing our bio-security initiatives in collaboration with government agencies. These strategic efforts will serve as catalysts for future growth, support our international expansion goals, and ensure scalable, long-term success. By optimizing our cost structure, refining our existing operations, and pursuing strategic acquisitions, XWELL is positioning itself for sustainable financial and operational growth while maximizing shareholder value.

Competition

Our domestic units operate within many of the largest and most heavily trafficked airports in the United States. The balance of the domestic market is highly fragmented and is represented largely by small, privately-owned entities. The largest domestic competitor operated 9 locations in 7 airports in the United States.

Our Market

Airport retailers differ significantly from traditional retailers. Unlike traditional retailers, airport retailers benefit from a steady and predictable flow of traffic from a constantly changing customer base. Airport retailers also benefit from “dwell time,” the period after travelers have passed through airport security and before they board an aircraft. For over 21 years, increased security requirements have led travelers to spend more time at the airport. In addition, in anticipation of the long and often stressful security lines, travelers allow for more time to get through security and, as a result, often experience increased downtime prior to boarding. XWELL is uniquely positioned to address this gap focusing on an expedient experience that still allows its customers to escape the hectic confines of the airport.

To take advantage of growing demand for unique travel wellness products, XWELL has made significant investments in a new retail offering that addresses this growing consumer demand. Further, as more airports exchange services for more traditional food and beverage providers, XWELL is positioned to take advantage of passenger demand for healthier and bio-nutrient rich snack and food offerings as part of its grab and go strategy.

The competition for airplane landings has forced airports to lower landing fees, which in turn has necessitated augmenting their retail offerings to offset budget shortfalls. Infrastructure projects at airports across the country, again intended to make an airport more desirable to airlines, require funding from bond issuances that in turn rely upon, in part, the expected minimum rent guarantees and expected income from concessionaires.

Equally as important to the industry growth is XWELL’s flexible, valuable, and desirable retail format and footprint within the airport retail segment. XWELL historically opened multiple locations annually, which have ranged in size from 200 square feet to 2,600 square feet, with a typical size of approximately 800 square feet. XWELL has been able to adapt its operating model to almost any size location available in space constrained airports. This increased flexibility compared to other retail concepts has allowed and will continue to allow XWELL to operate multiple stores within an airport, including in some cases for different concepts.

The acquisition of Naples Wax Center was intended to support the Company’s strategy of expanding out-of-airport locations to diversify its portfolio and reduce reliance on in-airport operations. However, certain Naples Wax Center locations have experienced operating challenges, which resulted in the recognition of impairment charges during the year.

Although we have historically focused our growth on the airport space, our strategy continues to shift with further emphasis on growth outside the airport—in and out of travel focused centers. This shift includes taking our XpresSpa brand out of the airport and into other transit centers such as rail terminals. It also includes growth through acquisition such as Naples Wax Centers where we can apply our wellness pedigree to expand that business from both a location standpoint and from a diversification of products and services standpoint.

Our goal continues to be opportunistic expansion outside the airport and we believe our family of brands will help to serve that growth strategy.

Regulation

Our operations are subject to a range of laws and regulations adopted by national, regional, and local authorities from the various jurisdictions in which we operate, including those relating to, among others, licensing (e.g., massage, nail, and cosmetology), public health and safety and fire codes. Failure to obtain or retain required licenses and approvals, including those related to licensing, public health and safety and fire codes, would adversely affect our operations. Although we have not experienced, and do not anticipate, significant problems obtaining required licenses, permits or approvals, any difficulties, delays or failures in obtaining such licenses, permits or approvals could delay or prevent the opening, or adversely impact the viability, of our operations.

Airport authorities in the United States frequently require that our airport concessions meet minimum Airport Concession Disadvantaged Business Enterprise (“ACDBE”) participation requirements. The Department of Transportation’s (“DOT”) ACDBE program is implemented by recipients of DOT Federal Financial Assistance, including airport agencies that receive federal funding. The ACDBE program is administered by the Federal Aviation Administration (“FAA”), state and

local ACDBE certifying agencies and individual airports. The ACDBE program is designed to help ensure that small firms owned and controlled by socially and economically disadvantaged individuals can compete for airport contracting and concession opportunities in domestic passenger service airports. The ACDBE regulations require that airport recipients establish annual ACDBE participation goals, review the scope of anticipated large prime contracts throughout the year, and establish contract specific ACDBE participation goals. We generally meet the contract specific goals through an agreement providing for co-ownership of the retail location with a disadvantaged business enterprise. Frequently, and within the guidelines issued by the FAA, we may lend money to ACDBEs in connection with concession agreements in order to help the ACDBE fund the capital investment required under a concession agreement. The rules and regulations governing the certification of ACDBE participation in airport concession agreements are complex, and ensuring ongoing compliance is costly and time consuming. Further, if we fail to comply with the minimum ACDBE participation requirements in our concession agreements, we may be held responsible for breach of contract, which could result in the termination of a concession agreement and monetary damages. See “